| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.38 | 5e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |